Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 1
2007 2
2008 2
2009 3
2010 1
2011 2
2012 2
2013 4
2014 1
2015 1
2016 1
2017 2
2018 4
2019 1
2020 7
2021 2
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
"Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?
Kolling S, Ventre F, Geuna E, Milan M, Pisacane A, Boccaccio C, Sapino A, Montemurro F. Kolling S, et al. Among authors: pisacane a. Front Oncol. 2020 Jan 17;9:1546. doi: 10.3389/fonc.2019.01546. eCollection 2019. Front Oncol. 2020. PMID: 32010631 Free PMC article. Review.
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary.
Brundu S, Napolitano V, Franzolin G, Lo Cascio E, Mastrantonio R, Sardo G, Cascardi E, Verginelli F, Sarnataro S, Gambardella G, Pisacane A, Arcovito A, Boccaccio C, Comoglio PM, Giraudo E, Tamagnone L. Brundu S, et al. Among authors: pisacane a. EMBO Mol Med. 2023 Mar 8;15(3):e16104. doi: 10.15252/emmm.202216104. Epub 2023 Feb 1. EMBO Mol Med. 2023. PMID: 36722641 Free PMC article.
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
Giraudo L, Cattaneo G, Gammaitoni L, Iaia I, Donini C, Massa A, Centomo ML, Basiricò M, Vigna E, Pisacane A, Picciotto F, Berrino E, Marchiò C, Merlini A, Paruzzo L, Poletto S, Caravelli D, Biolato AM, Bortolot V, Landoni E, Ventin M, Ferrone CR, Aglietta M, Dotti G, Leuci V, Carnevale-Schianca F, Sangiolo D. Giraudo L, et al. Among authors: pisacane a. J Exp Clin Cancer Res. 2023 Nov 22;42(1):310. doi: 10.1186/s13046-023-02884-x. J Exp Clin Cancer Res. 2023. PMID: 37993874 Free PMC article.
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition.
Verginelli F, Pisacane A, Gambardella G, D'Ambrosio A, Candiello E, Ferrio M, Panero M, Casorzo L, Benvenuti S, Cascardi E, Senetta R, Geuna E, Ballabio A, Montemurro F, Sapino A, Comoglio PM, Boccaccio C. Verginelli F, et al. Among authors: pisacane a. Nat Commun. 2021 May 3;12(1):2498. doi: 10.1038/s41467-021-22643-w. Nat Commun. 2021. PMID: 33941777 Free PMC article.
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.
Corso S, Cargnelutti M, Durando S, Menegon S, Apicella M, Migliore C, Capeloa T, Ughetto S, Isella C, Medico E, Bertotti A, Sassi F, Sarotto I, Casorzo L, Pisacane A, Mangioni M, Sottile A, Degiuli M, Fumagalli U, Sgroi G, Molfino S, De Manzoni G, Rosati R, De Simone M, Marrelli D, Saragoni L, Rausei S, Pallabazzer G, Roviello F, Cassoni P, Sapino A, Bass A, Giordano S. Corso S, et al. Among authors: pisacane a. Neoplasia. 2018 May;20(5):443-455. doi: 10.1016/j.neo.2018.02.003. Epub 2018 Mar 23. Neoplasia. 2018. PMID: 29574251 Free PMC article.
Altered molecular pathways in melanocytic lesions.
Scatolini M, Grand MM, Grosso E, Venesio T, Pisacane A, Balsamo A, Sirovich R, Risio M, Chiorino G. Scatolini M, et al. Among authors: pisacane a. Int J Cancer. 2010 Apr 15;126(8):1869-1881. doi: 10.1002/ijc.24899. Int J Cancer. 2010. PMID: 19795447 Free article.
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Fiorino E, Merlini A, D'Ambrosio L, Cerviere I, Berrino E, Marchiò C, Giraudo L, Basiricò M, Massa A, Donini C, Leuci V, Rotolo R, Galvagno F, Vitali L, Proment A, Ferrone S, Pisacane A, Pignochino Y, Aglietta M, Grignani G, Mesiano G, Sangiolo D. Fiorino E, et al. Among authors: pisacane a. Int J Mol Sci. 2022 Sep 8;23(18):10368. doi: 10.3390/ijms231810368. Int J Mol Sci. 2022. PMID: 36142281 Free PMC article.
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.
Gammaitoni L, Giraudo L, Macagno M, Leuci V, Mesiano G, Rotolo R, Sassi F, Sanlorenzo M, Zaccagna A, Pisacane A, Senetta R, Cangemi M, Cattaneo G, Martin V, Coha V, Gallo S, Pignochino Y, Sapino A, Grignani G, Carnevale-Schianca F, Aglietta M, Sangiolo D. Gammaitoni L, et al. Among authors: pisacane a. Clin Cancer Res. 2017 May 1;23(9):2277-2288. doi: 10.1158/1078-0432.CCR-16-1524. Epub 2016 Nov 4. Clin Cancer Res. 2017. PMID: 27815354 Free article.
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.
D'Ambrosio L, Palesandro E, Boccone P, Tolomeo F, Miano S, Galizia D, Manca A, Chiara G, Bertotto I, Russo F, Campanella D, Venesio T, Sangiolo D, Pignochino Y, Siatis D, De Simone M, Ferrero A, Pisacane A, Dei Tos AP, Aliberti S, Aglietta M, Grignani G. D'Ambrosio L, et al. Among authors: pisacane a. Eur J Cancer. 2017 Jun;78:122-132. doi: 10.1016/j.ejca.2017.03.025. Epub 2017 Apr 24. Eur J Cancer. 2017. PMID: 28448856
45 results